← Back to Search

Communication Training for Family Caregiving

N/A

Waitlist Available

Led By Talia Zaider, PhD

Research Sponsored by Memorial Sloan Kettering Cancer Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 2 years

Awards & highlights

No Placebo-Only Group

Summary

This trial will provide a communication training program to inpatient nurses and social workers at Memorial Sloan Kettering Cancer Center to help them assist caregiving families.

Who is the study for?

This trial is for nurses and social workers at MSKCC who can attend most training sessions. They'll work with families of inpatient cancer patients, including a designated family friend involved in care. Excluded are those under 12, non-English speakers, or anyone with severe cognitive impairment.

What is being tested?

The study tests a communication training program called Working with the Caregiving Family (WCF). It aims to improve how healthcare providers support and interact with families of hospitalized cancer patients through didactic and consolidation sessions.

What are the potential side effects?

Since this trial involves educational interventions rather than medical treatments, traditional physical side effects are not applicable. Participants may experience emotional or psychological responses to the training content.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 2 years

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~2 years

This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 years for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Provider outcomes

Secondary study objectives

patient and/or family members'outcomes

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups

Experimental Treatment

Group I: Working with the Caregiving Family (WCF) trainingExperimental Treatment2 Interventions

This is a new training curriculum for inpatient oncology providers called Working with the Caregiving Family (WCF) training, a program designed to teach MSKCC inpatient staff to address family-level concerns during acute hospitalization. The WCF training will teach staff to recognize and inquire about areas of family distress that are likely to impact the caregiving process; to provide brief, supportive interventions, and/or to transition families to specialized support services when needed. We will provide staff with skills to address especially challenging family situations (e.g., noncompliance with medical care, conflict, poor communication) in collaborative and compassionate ways. We will teach clinicians to intervene and respond more effectively when problematic relationships develop within families or between families and larger systems (e.g., medical team, institutional programs).

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

questionnaires

2008

Completed Phase 2

~4390

Do I qualify?Apply below to find out